Steffen Pietzke

2015 - PDL BioPharma

In 2015, Steffen Pietzke earned a total compensation of $360.7K as Controller and Chief Accounting Officer at PDL BioPharma.

Compensation breakdown

Non-Equity Incentive Plan$87,750
Salary$134,924
Stock Awards$100,256
Other$37,754
Total$360,684

Pietzke received $134.9K in salary, accounting for 37% of the total pay in 2015.

Pietzke also received $87.8K in non-equity incentive plan, $100.3K in stock awards and $37.8K in other compensation.

Rankings

In 2015, Steffen Pietzke's compensation ranked 11,871st out of 13,638 executives tracked by ExecPay. In other words, Pietzke earned more than 13.0% of executives.

ClassificationRankingPercentile
All
11,871
out of 13,638
13th
Division
Manufacturing
4,559
out of 5,187
12th
Major group
Chemicals And Allied Products
1,674
out of 1,857
10th
Industry group
Drugs
1,386
out of 1,531
10th
Industry
Biological Products, Except Diagnostic Substances
236
out of 260
9th
Source: SEC filing on April 28, 2017.

Pietzke's colleagues

We found five more compensation records of executives who worked with Steffen Pietzke at PDL BioPharma in 2015.

2015

John McLaughlin

PDL BioPharma

Chief Executive Officer

2015

Peter Garcia

PDL BioPharma

Chief Financial Officer

2015

Christopher Stone

PDL BioPharma

General Counsel

2015

Danny Hart

PDL BioPharma

Vice President, Business Development

2015

David Montez

PDL BioPharma

Chief Accounting Officer

News

You may also like